Generic multi-step therapeutic treatment protocol
AssigneeMedtronic, Inc.
InventorsPeter J. Kovach, Craig R. Lang, David C. Ullestad
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedtronic, Inc.
InventorsPeter J. Kovach, Craig R. Lang, David C. Ullestad
Estimating the term…
A generic treatment protocol is disclosed for therapeutically treating a patient via an implantable treatment device. Treatment steps can be defined to start and end at absolute times, or can be programmed via telemetry to start a certain amount of time after termination of a previously executed treatment step. Treatment steps have a treatment rate or dose attribute and a duration attribute. Treatment steps may optionally enable patient-activated bolus overlays. Patient-activated rate or dosage adjustments can also optionally be enabled. Repeated-execution treatment-step groups are also provided. Such treatment-step groups can have start and end times, a group duration, and a group total dose, each defined in a manner similar to that for a treatment step. Treatment-step groups include a repetition count, which could be set to a value that causes the group to repeat forever. Single execution treatment steps can, accordingly, be programmed to execute before and/or after a repeated-execution treatment-step group.
A computer-readable medium containing computer-executable instructions that cause a human-implantable therapeutic treatment device to perform a specific therapeutic treatment protocol by performing steps comprising:
A system for causing a human-implantable therapeutic treatment device to perform a specific therapeutic treatment protocol, the system comprising:
Dependencies are inferred from the claim text.